<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The studies concerning the association between Helicobacter pylori status and colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath>, <z:e sem="disease" ids="C0850639" disease_type="Neoplastic Process" abbrv="">premalignant lesions</z:e> of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e>, are not consistent </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: This cross-sectional study investigated the association of colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> with H. pylori <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in a consecutive series of 2,195 asymptomatic average-risk subjects who underwent screening colonoscopy and H. pylori testing </plain></SENT>
<SENT sid="2" pm="."><plain>Multivariate analyses were adjusted for potential relevant confounders, including age, sex, smoking, alcohol consumption, family history of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, and regular use of aspirin </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, we performed a systematic literature review and meta-analysis of available studies, including the current study, to clarify whether H. pylori <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> is associated with an increased risk of colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Among 2,195 eligible subjects, 1,253 subjects were H. pylori seropositive and 942 subjects were seronegative </plain></SENT>
<SENT sid="5" pm="."><plain>In the H. pylori (+) group, the prevalence of colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> and advanced <z:mpath ids='MPATH_270'>adenoma</z:mpath> was significantly higher than in the H. pylori (-) group (25.3 vs. 20.1 %, p = 0.004 and 6.1 vs. 2.9 %, p &lt; 0.001, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>In our multivariate analysis, H. pylori seropositivity was an independent risk factor for overall colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> (OR = 1.36, 95 % CI = 1.10-1.68) and advanced <z:mpath ids='MPATH_270'>adenoma</z:mpath> (OR = 2.21, 95 % CI = 1.41-3.48) </plain></SENT>
<SENT sid="7" pm="."><plain>The positive association was confined in cases with any proximal <z:mpath ids='MPATH_270'>adenoma</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>In the meta-analysis, which included ten studies and 15,863 patients, the pooled OR for colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> related to H. pylori <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was 1.58 (95 % CI = 1.32-1.88) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Our results from this cross-sectional study and current studies included in our meta-analysis indicated that H. pylori <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was associated with a modest increase in the risk for colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> </plain></SENT>
</text></document>